GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (NAS:NEOG) » Definitions » Days Sales Outstanding
中文

Neogen (Neogen) Days Sales Outstanding : 64.62 (As of Feb. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Neogen Days Sales Outstanding?

Neogen's average Accounts Receivable for the three months ended in Feb. 2024 was $162.0 Mil. Neogen's Revenue for the three months ended in Feb. 2024 was $228.8 Mil. Hence, Neogen's Days Sales Outstanding for the three months ended in Feb. 2024 was 64.62.

The historical rank and industry rank for Neogen's Days Sales Outstanding or its related term are showing as below:

NEOG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.12   Med: 69.08   Max: 73
Current: 59.82

During the past 13 years, Neogen's highest Days Sales Outstanding was 73.00. The lowest was 56.12. And the median was 69.08.

NEOG's Days Sales Outstanding is ranked better than
64.44% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs NEOG: 59.82

Neogen's Days Sales Outstanding increased from Feb. 2023 (60.44) to Feb. 2024 (64.62).


Neogen Days Sales Outstanding Historical Data

The historical data trend for Neogen's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Days Sales Outstanding Chart

Neogen Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.23 73.00 68.76 66.30 56.12

Neogen Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.44 56.54 57.97 57.26 64.62

Competitive Comparison of Neogen's Days Sales Outstanding

For the Diagnostics & Research subindustry, Neogen's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Neogen's Days Sales Outstanding falls into.



Neogen Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Neogen's Days Sales Outstanding for the fiscal year that ended in May. 2023 is calculated as

Days Sales Outstanding (A: May. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: May. 2022 ) + Accounts Receivable (A: May. 2023 )) / count ) / Revenue (A: May. 2023 )*Days in Period
=( (99.674 + 153.253) / 2 ) / 822.447*365
=126.4635 / 822.447*365
=56.12

Neogen's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

Days Sales Outstanding (Q: Feb. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Nov. 2023 ) + Accounts Receivable (A: Feb. 2024 )) / count ) / Revenue (A: Feb. 2024 )*Days in Period
=( (150.498 + 173.592) / 2 ) / 228.812*365 / 4
=162.045 / 228.812*365 / 4
=64.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neogen  (NAS:NEOG) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Neogen Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Neogen's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen (Neogen) Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Executives
William T Boehm director
Douglas Edward Jones officer: Vice President, CCO 620 LESHER PLACE, LANSING MI 48912
Jason Warren Lilly officer: Vice President 620 LESHER PLACE, LANSING MI 48912
James P Tobin director 620 LESHER PLACE, LANSING MI 48895
David H. Naemura officer: VP & CFO C/O GATES INDUSTRIAL CORPORATION PLC, 1144 FIFTEENTH STREET, SUITE 1400, DENVER CO 80202
Amy M Rocklin officer: Chief Legal & Reg. Officer 620 LESHER PLACE, LANSING MI 48912
Steven J. Quinlan officer: VP & CFO 620 LESHER PLACE, LANSING MI 48912
Jeffrey D Capello director C/O NEOGEN CORP., 620 LESHER PLACE, LANSING MI 48912
Aashima Gupta director C/O NEOGEN CORPORATION, 620 LESHER PLACE, LANSING MI 48912
John Edward Adent officer: Chief Executive Officer 822 7TH STREET, SUITE 740, GREELEY CO 80631
Darci L Vetter director 620 LESHER PLACE, LANSING MI 48912
Ronald D Green director 620 LESHER PLACE, LANSING MI 48912
James C Borel director 1007 MARKET STREET, WILMINGTON DE 19898
Terri A Morrical officer: General Manager
G Bruce Papesh director 726 APPLEGATE LANE, EAST LANSING MI 48823